Show simple item record

dc.creatorMello, Michelle M.en
dc.creatorClarridge, Brian R.en
dc.creatorStuddert, David M.en
dc.date.accessioned2016-01-08T23:41:36Zen
dc.date.available2016-01-08T23:41:36Zen
dc.date.created2005-07en
dc.date.issued2005-07en
dc.identifierdoi:10.1080/08989620500216380en
dc.identifier.bibliographicCitationAccountability in Research 2005 July-September; 12(3): 163- 191en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Researchers'+views+of+the+acceptability+of+restrictive+provisions+in+clinical+trial+agreements+with+industry+sponsors&title=Accountability+in+Research+&volume=12&issue=3&date=2005-07&au=Mello,+Michelle+M.;+Clarridge,+Brian+R.;+Studdert,+David+M.en
dc.identifier.urihttp://dx.doi.org/10.1080/08989620500216380en
dc.identifier.urihttp://hdl.handle.net/10822/980501en
dc.description.abstractWe conducted a mail survey of 884 U.S. medical school faculty active in clinical research to elicit their views about the acceptability of provisions in contracts for industry-sponsored clinical trials that would restrict investigators' academic freedom and control over trials. We compared their responses to results from a similar survey of research administrators at 107 medical schools. There was substantial variation among clinical researchers in their acceptability judgments, with a relatively large proportion of clinical trial investigators willing to accept provisions tha give industry sponsors considerable control over the dissemination of research results. There were significant differences in the perceptions of clinical trial investigators versus other recently published clinical researchers; investigators with a high versus low percentage of research support from industry; junior versus senior faculty; and investigators at institutions with high versus low National Institute of Health (NIH) funding ranks. There was also a significant divergence of views in a number of areas between clinical trialists and research administrators who negotiate clinical trial contracts on their behalf. Medical school faculty could benefit from additional guidance about what their institution views as acceptable parameters for industry-sponsored clinical trial agreements.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:286244en
dc.subjectAdministratorsen
dc.subjectClinical Trialsen
dc.subjectContractsen
dc.subjectClinical Researchen
dc.subjectFacultyen
dc.subjectFreedomen
dc.subjectHealthen
dc.subjectIndustryen
dc.subjectInvestigatorsen
dc.subjectMedical Schoolsen
dc.subjectResearchen
dc.subjectResearch Supporten
dc.subjectResearchersen
dc.subjectSchoolsen
dc.subjectSurveyen
dc.subject.classificationSocial Control of Science and Technologyen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationScientific Research Ethicsen
dc.titleResearchers' Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements With Industry Sponsorsen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885